NDUFAB1 and allergic disease: Table 2 presents 14 key compounds with a degree value exceeding 1 in the network, representing potential key compounds involved in ACP’s unique mechanism in treating allergic diseases compared to anti-allergic drugs. The common core target-compound network (Figure 4D) includes 40 nodes (9 targets, 31 compounds) connected by 57 edges. Table 2 presents 15 key compounds with a degree value of 2 or higher in this network, representing potential key compounds contributing to the common mechanisms of ACP in the treatment of allergic diseases compared to anti-allergic drugs.